SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-14-031016
Filing Date
2014-04-28
Accepted
2014-04-28 09:06:22
Documents
3
Effectiveness Date
2014-04-28

Document Format Files

Seq Description Document Type Size
1 DEFA14A a14-10833_3defa14a.htm DEFA14A 36356
2 GRAPHIC g108333cai001.gif GRAPHIC 72121
3 GRAPHIC g108333cai002.gif GRAPHIC 74425
  Complete submission text file 0001104659-14-031016.txt   239524
Mailing Address 2 MERCER ROAD NATICK MA 01760
Business Address 2 MERCER ROAD NATICK MA 01760 508-975-4820
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36167 | Film No.: 14787609
SIC: 2834 Pharmaceutical Preparations